Alpha-Ketoglutaric Acid

Alpha-Ketoglutaric Acid

SCHEMBL174469

CC1CNCCc2ccccc21.O=C(O)CCC(=O)C(=O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 16/20 0.65
HTR2A P28223 13/20 0.65
HTR2B P41595 11/20 0.65
ADRB1 P08588 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
CNR1 P21554 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
HRH1 P35367 1/20 0.44
KCNH2 Q12809 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
TSHR P16473 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
DRD2 P14416 1/20 0.40
DRD1 P21728 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL170444 0.94 HTR2C (0.74) HTR2CHTR2AHTR2BADRB1HTR1A
Adipic Acid SCHEMBL173678 0.88 HTR2C (0.70) HTR2CHTR2AHTR2BADRB1HTR1A
Malonic Acid SCHEMBL174816 0.85 HTR2C (0.74) HTR2CHTR2AHTR2BADRB1HTR1A
Glycolic Acid SCHEMBL173573 0.85 HTR2C (0.74) HTR2CHTR2AHTR2BADRB1HTR1A
Lorcaserin SCHEMBL173294 0.84 HTR2A (0.67) HTR2CHTR2AHTR2BADRB1HTR1A
Alpha-Ketoglutaric Acid SCHEMBL162746 0.83 TAAR1 (0.42) HTR2CHTR2AHTR2BADRA2CTAAR1
Glutamic Acid SCHEMBL174564 0.81 HTR2C (0.59) HTR2CHTR2AHTR2BADRB1HTR1A
Alpha-Ketoglutaric Acid SCHEMBL16464850 0.81 HTR2C (0.53) HTR2CHTR2BTSHRNPSR1DRD2
SCHEMBL164205 0.81 HTR2C (1.00) HTR2CHTR2AHTR2BADRB1HTR1A
Fumaric Acid SCHEMBL175130 0.80 HTR2C (0.74) HTR2CHTR2AHTR2BADRB1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611449-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT Arena Pharmaceuticals, Inc. (US) 2013-07-10 EP disclosed
WO-2012030939-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed